Related Experiment Videos
Crohn's disease: management in adults, children and young people - concise guidance
Gloria Sz Tun1, Sarah Cripps2, Alan J Lobo3
1Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Insights
Crohn
Area of Science:
- Gastroenterology and Internal Medicine
- Clinical Practice Guidelines
Background:
- Crohn's disease (CD) is a chronic inflammatory gastrointestinal disorder characterized by acute flares and complications.
- Effective management necessitates multidisciplinary specialist input for treatment selection and complication management.
Purpose of the Study:
- To provide concise recommendations for the implementation of NICE Clinical Guideline 152 (CG152).
- To guide healthcare professionals in managing Crohn's disease.
Main Methods:
- Focuses on key recommendations from NICE Clinical Guideline 152 (CG152).
- Highlights the importance of specialist input and monitoring for Crohn's disease management.
Main Results:
- Emphasizes the need for integrated care involving gastroenterologists, surgeons, nurses, and pharmacists.
- Stresses the critical role of monitoring patients and their medications to prevent and identify complications.
Conclusions:
- Implementation of NICE CG152 is crucial for optimal Crohn's disease patient care.
- Multidisciplinary collaboration and vigilant monitoring are key to managing Crohn's disease effectively and preventing complications.
Abstract:
Crohn's disease (CD) is a chronic inflammatory condition of the gastrointestinal tract. Individuals with CD present with acute inflammatory exacerbations as well as acute and chronic complications. Management requires specialist input from gastroenterologists, colorectal surgeons, nurse specialists and pharmacists as well as general and primary care physicians to allow appropriate selection of treatment options including surgery and rapid assessment and treatment of those with acute exacerbations. Monitoring of the individual and their medication is crucial in preventing and recognising complications including those associated with treatment. This concise guideline focuses on recommendations from National Institute for Health and Care Excellence (NICE) -Clinical -Guideline 152 (CG152) considered of key importance for implementation.